Treatable Intellectual Disability

l.o. Glutaric Acidemia I

BIOCHEMICAL DEFECT

Stacks Image 286

DIAGNOSIS

Gene
GCDH (AR)

Diagnostic Test
Urine Organic Acids

Stacks Image 287

SIGNS & SYMPTOMS

Neurological
Encephalopathic crisis, stroke, dystonia, basal ganglia lesions (MRIscan)

Non-Neurological
Macrocephaly, cardiomyopathy

Stacks Image 288

THERAPY

Treatment
Lysine Restriction, Carnitine Supplements

Level of Evidence
2c

Clinical Practice
Standard of Care

Treatment Effect
Prevents metabolic decompensation; stabilizes clinical deterioration; improves neurological & systemic manifestations



Stacks Image 289
Stacks Image 290

Late-Onset Glutaric Acidemia I

Glutaryl-Coenzyme A (CoA) dehydrogenase deficiency (GDD) is an enzyme deficiency affecting lysine and tryptophan degradation. It is clinically characterized by sudden onset of encephalopathic crisis which results in bilateral striatal damage and severe dystonic dyskinetic movement disorder. Crisis usually occurs between the ages 6 and 12 months and is triggered by febrile illness. During the preencephalopathic phase children may have mild developmental delay and muscular hypotonia. Often progressive macrocephaly is apparent from birth and MRI shows frontotemporal atrophy with significant subdural fluid spaces. Not all affected individuals may develop crisis. Some patients may remain asymptomatic even if untreated, some develop slowly progressive dystonia an leukoencephalopathy.

No information available from this source.

This disease is not (yet) listed on their website.